Overview:Cancer Trials Australia (CTA) was established in 2003 and is now an international leader in facilitation of clinical trials, playing a pivotal role in developing new therapies and the advancement of patient care.
CTA is a member-based clinical trial network spread over 23 hospitals and research organisations nationally.
CTA’s strength lies in the collective intellectual and technical expertise of its members and the co-ordination of their resources to undertake high-quality clinical trials that include early phase and first time in human trials. We specialise in providing ethics and governance submissions, including budget and contract negotiations, drug development advisory services, management of trials via a clinical trial management system (CTMS) and trial financial management services.
CTA also provides an advocacy service for its members via engagement with State and Federal Government agencies along with providing opportunities for regular engagement between members.